|
|
|
Volumn 52, Issue 477, 2002, Pages 341-
|
|
DTCA in New Zealand: The challenge of finding an acceptable balance
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIOBESITY AGENT;
DRUG;
SILDENAFIL;
TETRAHYDROLIPSTATIN;
BUDGET;
CONSULTATION;
CONSUMER;
DOCTOR PATIENT RELATION;
DRUG CONTROL;
DRUG COST;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG RESEARCH;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
GENERAL PRACTITIONER;
GOVERNMENT;
HEALTH CARE FINANCING;
HEALTH CARE SYSTEM;
HEALTH EDUCATION;
HEALTH MAINTENANCE ORGANIZATION;
LIFESTYLE;
MEDICAL DECISION MAKING;
MEDICAL PROFESSION;
NEW ZEALAND;
NOTE;
OUTCOMES RESEARCH;
PATIENT SATISFACTION;
PRESCRIPTION;
PUBLIC HEALTH;
PUBLIC OPINION;
RESOURCE MANAGEMENT;
RISK BENEFIT ANALYSIS;
TELEVISION;
ADVERTISING;
DRUG INDUSTRY;
FAMILY PRACTICE;
HUMANS;
NEW ZEALAND;
PUBLIC HEALTH;
WORKLOAD;
|
|
EID: 0036526468
PISSN: 09601643
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (3)
|
